JP2011518194A5 - - Google Patents

Download PDF

Info

Publication number
JP2011518194A5
JP2011518194A5 JP2011505263A JP2011505263A JP2011518194A5 JP 2011518194 A5 JP2011518194 A5 JP 2011518194A5 JP 2011505263 A JP2011505263 A JP 2011505263A JP 2011505263 A JP2011505263 A JP 2011505263A JP 2011518194 A5 JP2011518194 A5 JP 2011518194A5
Authority
JP
Japan
Prior art keywords
shal
linker
ligand
phenoxy
chloro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011505263A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011518194A (ja
JP5623384B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/041276 external-priority patent/WO2009132020A2/en
Publication of JP2011518194A publication Critical patent/JP2011518194A/ja
Publication of JP2011518194A5 publication Critical patent/JP2011518194A5/ja
Application granted granted Critical
Publication of JP5623384B2 publication Critical patent/JP5623384B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011505263A 2008-04-21 2009-04-21 選択的高親和性リガンドおよびこれらを作製する方法 Expired - Fee Related JP5623384B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4671208P 2008-04-21 2008-04-21
US61/046,712 2008-04-21
PCT/US2009/041276 WO2009132020A2 (en) 2008-04-21 2009-04-21 Selective high-affinity polydentate ligands and methods of making such

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014043517A Division JP2014122234A (ja) 2008-04-21 2014-03-06 選択的高親和性リガンドおよびこれらを作製する方法

Publications (3)

Publication Number Publication Date
JP2011518194A JP2011518194A (ja) 2011-06-23
JP2011518194A5 true JP2011518194A5 (cg-RX-API-DMAC10.html) 2013-05-02
JP5623384B2 JP5623384B2 (ja) 2014-11-12

Family

ID=41217391

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011505263A Expired - Fee Related JP5623384B2 (ja) 2008-04-21 2009-04-21 選択的高親和性リガンドおよびこれらを作製する方法
JP2014043517A Withdrawn JP2014122234A (ja) 2008-04-21 2014-03-06 選択的高親和性リガンドおよびこれらを作製する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014043517A Withdrawn JP2014122234A (ja) 2008-04-21 2014-03-06 選択的高親和性リガンドおよびこれらを作製する方法

Country Status (8)

Country Link
US (5) US9884070B2 (cg-RX-API-DMAC10.html)
EP (1) EP2268654B1 (cg-RX-API-DMAC10.html)
JP (2) JP5623384B2 (cg-RX-API-DMAC10.html)
CN (1) CN102083850B (cg-RX-API-DMAC10.html)
AU (1) AU2009239491B2 (cg-RX-API-DMAC10.html)
CA (1) CA2721980C (cg-RX-API-DMAC10.html)
ES (1) ES2613844T3 (cg-RX-API-DMAC10.html)
WO (1) WO2009132020A2 (cg-RX-API-DMAC10.html)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9075059B2 (en) 2009-11-05 2015-07-07 University Of Virginia Patent Foundation Compositions and methods for detecting plectin-1 as a biomarker for cancer
EP2794565B1 (en) * 2011-12-21 2017-07-26 Novira Therapeutics Inc. Hepatitis b antiviral agents
JP6103832B2 (ja) 2012-06-25 2017-03-29 Hoya株式会社 Egfr結合性ペプチド
EP3019559A4 (en) 2013-08-22 2017-04-05 Sony Corporation Water soluble fluorescent or colored dyes and methods for their use
US20170290892A1 (en) * 2014-07-14 2017-10-12 Peg Biosciences, Inc. Polymeric enkephalin prodrugs
CN105985524A (zh) * 2015-02-10 2016-10-05 北京师范大学 针对特定靶标具备指纹识别特征的多肽复合物分子的构建方法
KR102646956B1 (ko) 2015-02-26 2024-03-14 소니그룹주식회사 페닐에티닐나프탈렌 염료 및 이의 사용 방법
WO2016138461A1 (en) 2015-02-26 2016-09-01 Sony Corporation Water soluble fluorescent or colored dyes comprising conjugating groups
KR102765335B1 (ko) 2015-05-11 2025-02-13 소니그룹주식회사 초휘도 이량체성 또는 중합체성 염료
US10542961B2 (en) 2015-06-15 2020-01-28 The Research Foundation For The State University Of New York System and method for infrasonic cardiac monitoring
CN105678112B (zh) * 2016-02-03 2018-08-03 中国农业科学院北京畜牧兽医研究所 一种计算机辅助筛选小分子化合物靶标适配体的实现方法
EP3436528B1 (en) 2016-04-01 2025-07-02 Sony Group Corporation Ultra bright dimeric or polymeric dyes with rigid spacing groups
BR112018070164B1 (pt) 2016-04-01 2022-09-27 Sony Corporation Of America Corantes diméricos ou poliméricos ultrabrilhantes
CN109153860B (zh) 2016-04-06 2021-04-23 索尼公司 具有间隔连接体基团的超高亮二聚体或聚合物染料
JP7527537B2 (ja) 2016-05-10 2024-08-05 ソニーグループ株式会社 ペプチド骨格を有する超明色ポリマー染料
US11390754B2 (en) 2016-05-10 2022-07-19 Sony Corporation Compositions comprising a polymeric dye and a cyclodextrin and uses thereof
BR112018073199A2 (pt) 2016-05-11 2019-04-16 Sony Corporation corantes diméricos ou poliméricos ultrabrilhantes
EP3464477A1 (en) 2016-06-06 2019-04-10 Sony Corporation Ionic polymers comprising fluorescent or colored reporter groups
WO2018022925A1 (en) 2016-07-29 2018-02-01 Sony Corporation Ultra bright dimeric or polymeric dyes and methods for preparation of the same
WO2018053463A1 (en) 2016-09-19 2018-03-22 H. Lee Moffitt Cancer Center And Research Institute, Inc. Artificial antigen presenting cells for genetic engineering of immune cells
WO2018098384A1 (en) * 2016-11-22 2018-05-31 Regents Of The University Of California Segregation modulation for immunotherapy
WO2018152434A1 (en) * 2017-02-17 2018-08-23 The Regents Of The University Of California Systems and methods for making assignments in isotope-labelled proteins using nuclear magnetic resonance data
US12077590B2 (en) 2017-02-22 2024-09-03 H. Lee Moffitt Cancer Center And Research Institute, Inc. Bispecific antibody for cancer immunotherapy
US12290571B2 (en) * 2017-10-05 2025-05-06 Sony Group Corporation Programmable dendritic drugs
KR20260011205A (ko) 2017-10-05 2026-01-22 소니그룹주식회사 프로그램가능한 중합체성 약물
SG11202002967SA (en) * 2017-11-01 2020-05-28 Arrowhead Pharmaceuticals Inc Integrin ligands and uses thereof
CN111836645A (zh) 2017-11-16 2020-10-27 索尼公司 可编程的聚合药物
EP3737417B1 (en) 2018-01-12 2025-08-27 Sony Group Corporation Phosphoalkyl ribose polymers comprising biologically active compounds
WO2019140128A1 (en) 2018-01-12 2019-07-18 Sony Corporation Phosphoalkyl polymers comprising biologically active compounds
US12076407B2 (en) 2018-01-12 2024-09-03 Sony Group Corporation Polymers with rigid spacing groups comprising biologically active compounds
EP3769085B1 (en) 2018-03-19 2022-08-24 Sony Group Corporation Use of divalent metals for enhancement of fluorescent signals
KR102864292B1 (ko) 2018-03-21 2025-09-26 소니그룹주식회사 링커 군을 갖는 중합체성 텐덤 염료
WO2019195466A1 (en) * 2018-04-03 2019-10-10 The Trustees Of Columbia University In The City Of New York Compositions for radiotherapy and uses therof
JP7580689B2 (ja) 2018-06-27 2024-11-12 ソニーグループ株式会社 デオキシリボースを含むリンカー基を有するポリマー色素
US12578342B2 (en) 2018-07-13 2026-03-17 Sony Group Corporation Polymeric dyes having a backbone comprising organophosphate units
CN109283842B (zh) * 2018-08-02 2022-01-07 哈尔滨工程大学 一种无人艇航迹跟踪智能学习控制方法
EP3861074A2 (en) 2019-09-26 2021-08-11 Sony Group Corporation Polymeric tandem dyes with linker groups
EP4038081A1 (en) 2019-09-30 2022-08-10 Sony Group Corporation Nucleotide probes
WO2021127583A1 (en) * 2019-12-20 2021-06-24 Shal Technologies, Inc. Selective high affinity ligand diagnostics and therapeutics
AU2021251875A1 (en) * 2020-04-10 2022-11-03 Seagen Inc. Charge variant linkers
EP4256078A1 (en) 2020-12-07 2023-10-11 Sony Group Corporation Spacing linker group design for brightness enhancement in dimeric or polymeric dyes
CN115043898B (zh) * 2021-03-08 2024-12-31 迈克生物股份有限公司 生物素化抗原衍生物及相关试剂盒和用途
CN113960317A (zh) * 2021-08-19 2022-01-21 深圳市辅酶医科技有限公司 一种测量生物样品中nad+浓度的生物传感器及方法
US20250095771A1 (en) * 2022-01-18 2025-03-20 NEC Laboratories Europe GmbH Methods of vaccine design
EP4497432A4 (en) * 2022-03-22 2025-07-30 Bion Inc PROTEIN DELIVERY COMPOSITION CONTAINING BILE SALT AND CATIONIC PEPTIDE AND USE THEREOF
WO2024059858A2 (en) * 2022-09-15 2024-03-21 Ligandal, Inc. Approaches to discovering, analyzing, and synthesizing compounds through automated in silico experimentation

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331647A (en) 1980-03-03 1982-05-25 Goldenberg Milton David Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers
US4361544A (en) 1980-03-03 1982-11-30 Goldenberg Milton David Tumor localization and therapy with labeled antibodies specific to intracellular tumor-associated markers
US4444744A (en) 1980-03-03 1984-04-24 Goldenberg Milton David Tumor localization and therapy with labeled antibodies to cell surface antigens
US5506337A (en) 1985-03-15 1996-04-09 Antivirals Inc. Morpholino-subunit combinatorial library and method
US5034223A (en) 1986-10-09 1991-07-23 Neorx Corporation Methods for improved targeting of antibody, antibody fragments, hormones and other targeting agents, and conjugates thereof
US4921690A (en) 1986-12-29 1990-05-01 City Of Hope Method of enhancing the biodistribution of antibody for localization in lesions
US6010902A (en) 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
US5010175A (en) 1988-05-02 1991-04-23 The Regents Of The University Of California General method for producing and selecting peptides with specific properties
US5601819A (en) 1988-08-11 1997-02-11 The General Hospital Corporation Bispecific antibodies for selective immune regulation and for selective immune cell binding
DE3909708A1 (de) 1989-03-23 1990-09-27 Boehringer Mannheim Gmbh Verfahren zur herstellung bispezifischer antikoerper
IE66205B1 (en) 1990-06-14 1995-12-13 Paul A Bartlett Polypeptide analogs
US5650489A (en) 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
AU8727291A (en) 1990-10-29 1992-06-11 Cetus Oncology Corporation Bispecific antibodies, method of production, and uses thereof
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5595721A (en) 1993-09-16 1997-01-21 Coulter Pharmaceutical, Inc. Radioimmunotherapy of lymphoma using anti-CD20
US5519134A (en) 1994-01-11 1996-05-21 Isis Pharmaceuticals, Inc. Pyrrolidine-containing monomers and oligomers
US5593853A (en) 1994-02-09 1997-01-14 Martek Corporation Generation and screening of synthetic drug libraries
US5539083A (en) 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5549974A (en) 1994-06-23 1996-08-27 Affymax Technologies Nv Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof
US5569588A (en) 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
DK0826695T3 (da) 1996-09-03 2002-04-15 Gsf Forschungszentrum Umwelt Tilintetgørelse af kontaminerende tumorceller i stamcelletransplantater med bispecifikke antistoffer
US6207805B1 (en) 1997-07-18 2001-03-27 University Of Iowa Research Foundation Prostate cell surface antigen-specific antibodies
EP1077724A2 (en) 1998-04-17 2001-02-28 The University Of Vermont Methods and products related to metabolic interactions in disease
US6217871B1 (en) 1998-10-28 2001-04-17 The Regents Of The University Of California Antigenic epitopes with LYM-1 reactivity and uses thereof
GB0016361D0 (en) 2000-07-03 2000-08-23 Chiron Spa Structure-based HCV drug design
US20020155109A1 (en) 2001-04-20 2002-10-24 Lynch David H. Bispecific antibodies that bind TRAIL-R1 and TRAIL-R2
WO2003002144A1 (en) 2001-06-26 2003-01-09 Imclone Systems Incorporated Bispecific antibodies that bind to vegf receptors
JP4381140B2 (ja) 2001-10-12 2009-12-09 シェーリング コーポレイション 免疫応答を調節するための二重特異性抗体の使用
IL161417A0 (en) * 2001-10-15 2004-09-27 Immunomedics Inc Affinity enhancement agents
DE10256530A1 (de) * 2002-12-04 2004-06-24 Degussa Ag Verfahren zur Herstellung von wasserfreiem Alkalisulfid
CA2534898A1 (en) 2003-08-08 2005-02-17 Immunomedics, Inc. Bispecific antibodies for inducing apoptosis of tumor and diseased cells
US7235641B2 (en) 2003-12-22 2007-06-26 Micromet Ag Bispecific antibodies
WO2005077065A2 (en) 2004-02-09 2005-08-25 The Regents Of The University Of California Selective high-affinity polydentate ligands and methods of making such
WO2006004910A2 (en) 2004-06-28 2006-01-12 Transtarget Inc. Improved bispecific antibodies
JO3421B1 (ar) 2011-06-20 2019-10-20 H Lundbeck As طريقة لإعطاء 1-((1ار.3س)-6-كلورو-3-فينيل-اندان-1-ايل)-1.2.2-ترايميثيل- بيبيرازين واملاجها لمعالجة انفصام الشخصية

Similar Documents

Publication Publication Date Title
Roy et al. Design and validation of fibroblast activation protein alpha targeted imaging and therapeutic agents
CN102083850B (zh) 选择性高亲和力多齿配体及其制备方法
Wang et al. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine− folate, a potential radiopharmaceutical for tumor imaging
US20210008232A1 (en) Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents for targeting prostate cancer
JP2009525946A (ja) 増強された薬理学的性質を有する活性物質を送達するための方法および組成物
JP2020073472A5 (cg-RX-API-DMAC10.html)
JP2011521897A5 (cg-RX-API-DMAC10.html)
JP2010521485A5 (cg-RX-API-DMAC10.html)
JP2018503679A5 (cg-RX-API-DMAC10.html)
JP2009532338A5 (cg-RX-API-DMAC10.html)
JP2013514329A5 (cg-RX-API-DMAC10.html)
US11160887B2 (en) Compositions for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same
JP2007511463A5 (cg-RX-API-DMAC10.html)
CN112770755A (zh) 平台药物fl118位置7和9衍生的类似物的组成,合成,制备和应用治疗人类疾病
JP2014501714A5 (cg-RX-API-DMAC10.html)
Awasthi et al. Biodistribution of radioiodinated adenovirus fiber protein knob domain after intravenous injection in mice
Nayak et al. Evaluation of 99mTc (I)-tricarbonyl complexes of fluoroquinolones for targeting bacterial infection
Neilio et al. Emerging head and neck tumor targeting contrast agents for the purpose of CT, MRI, and multimodal diagnostic imaging: a molecular review
RU2010129856A (ru) Новая вакцина для лечения связанных с микобактерией нарушений
Qiao et al. Novel 64Cu-labeled NOTA-conjugated lactam-cyclized alpha-melanocyte-stimulating hormone peptides with enhanced tumor to kidney uptake ratios
Braun et al. Synthesis, radiolabeling, and in vitro and in vivo characterization of heterobivalent peptidic agents for bispecific EGFR and integrin αvβ3 targeting
Kim et al. Monitoring the effect of PEGylation on polyethylenimine in vivo using nuclear imaging technique
JP7568708B2 (ja) 肺がんの診断方法
Bridger et al. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab ‘monoclonal antibody fragments
JP2004524323A5 (cg-RX-API-DMAC10.html)